Greylock Partners is one of the oldest venture capital firms, founded in 1965, with committed capital of over $3.5 billion under management. The firm focuses on early-stage companies in consumer and enterprise software. From Wikipedia
Manas AI aims to revolutionize cancer drug discovery using AI, starting with treatments for breast cancer, prostate cancer, and lymphoma.